Nifedipine Contraindication in Heart Failure with Reduced Ejection Fraction

Guideline-Based Contraindication

• The American College of Cardiology recommends that calcium channel-blocking drugs are not used as routine treatment in patients with heart failure with reduced ejection fraction (HFrEF), due to lack of benefit (Class III: No Benefit) 1
• The American College of Cardiology and American Heart Association guidelines state that calcium channel blocking drugs are not indicated as routine treatment for heart failure in patients with current or prior symptoms of heart failure and reduced left ventricular ejection fraction (LVEF) 2
• The American College of Cardiology and American Heart Association Hypertension Guidelines warn to avoid use of dihydropyridine calcium channel blockers like nifedipine in patients with HFrEF, noting that only amlodipine or felodipine may be used if absolutely required 3
• The American College of Cardiology and American Heart Association guidelines classify nondihydropyridine calcium channel blockers as potentially harmful in patients with low LVEF (Class III: Harm) 4

Safe Alternatives for Blood Pressure Control in HFrEF

• The American College of Cardiology recommends ACE inhibitors or ARBs as first-line treatment for both HFrEF and hypertension (Class I, Level A) 1
• The American College of Cardiology recommends beta-blockers (carvedilol, metoprolol succinate, or bisoprolol) to treat both HFrEF and hypertension simultaneously (Class I, Level A) 1
• The American College of Cardiology recommends hydralazine plus isosorbide dinitrate for additional blood pressure reduction if needed (Class I, Level A for African Americans; Class IIa, Level B for others) 1
• The American College of Cardiology and American Heart Association Hypertension Guidelines recommend thiazide or thiazide-type diuretics (chlorthalidone preferred) for hypertension while managing volume status 3

Mechanism of Harm and Alternative Antianginal Agents

• The negative inotropic effects and potential for worsening heart failure outweigh any blood pressure-lowering benefits of nifedipine in HFrEF patients 1, 2
• The American College of Cardiology recommends coronary revascularization evaluation first if ischemia is contributing to symptoms, and nitrates and beta-blockers as preferred antianginal agents in HFrEF 1
• The American College of Cardiology recommends ranolazine as an alternative antianginal agent that does not worsen heart failure 1
• Only amlodipine and felodipine have safety data in HFrEF, and should only be used when absolutely necessary and other options have been exhausted 2, 3